G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer

Molecular Carcinogenesis

Volumn 53, Issue 3, 2014, Pages 219-229

  Li, Yingfei ^a   Nie, Yuqiang ^a   Cao, Jie ^a   Tu, Sanfang ^b   Lin, Yong ^a   Du, Yanlei ^a   Li, Yuyuan ^a  

^a GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

EFNA1; Gastric cancer; Genetic variation; Has miR 200c; Susceptibility

Indexed keywords

EFNA1; GASTRIC CANCER; GENETIC VARIATION; HAS-MIR-200C; SUSCEPTIBILITY;

3' UNTRANSLATED REGIONS; BINDING SITES; BLOTTING, WESTERN; CASE-CONTROL STUDIES; EPHRIN-A1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; MUTAGENESIS, SITE-DIRECTED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 84894288474     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.21966     Document Type: Article

References (41)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90.
2. Polk DB, Peek RM. Helicobacter pylori: Gastric cancer and beyond. Nat Rev Cancer 2010; 10:403-414.
3. Milne AN, Carneiro F, O'Morain C, Offerhaus GJA. Nature meets nurture: Molecular genetics of gastric cancer. Hum Genet 2009; 126:615-628.
4. Sakamoto H, Yoshimura K, Saeki N, et al. Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet 2008; 40:730-740.
5. Shi Y, Hu Z, Wu C, Dai J, et al. A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1. Nat Genet 2011; 43:1215-1218.
6. Saeki N, Saito A, Choi IJ, et al. A functional single nucleotide polymorphism in mucin 1, at chromosome 1q22, determines susceptibility to diffuse-type gastric cancer. Gastroenterology 2011; 140:892-902.
7. Abnet CC, Freedman ND, Hu N, et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet 2010; 42:764-767.
8. Wang LD, Zhou FY, Li XM, et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet 2010; 42:759-763.
9. Freedman ML, Monteiro AN, Gayther SA, et al. Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet 2011; 43:513-518.
10. Saccone NL, Saccone SF, Goate AM, et al. In search of causal variants: Refining disease association signals using cross-population contrasts. BMC Genet 2008; 9:58.
11. Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell 2009; 136:642-655.
12. Richardson K, Lai CQ, Parnell LD, Lee YC, Ordovas JM. A Genome-wide survey for SNPs altering microRNA seed sites identifies functional candidates in GWAS. BMC Genomics 2011; 12:504.
13. Chin LJ, Ratner E, Leng S, et al. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res 2008; 68:8535-8540.
14. Landi D, Gemignani F, Naccarati A, et al. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis 2007; 29:579-584.
15. Gao Y, He Y, Ding J, et al. An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-13' untranslated region confers risk for hepatocellular carcinoma. Carcinogenesis 2009; 30:2064-2069.
16. Zhang L, Liu Y, Song F, et al. Functional SNP in the microRNA-367 binding site in the 3'UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification. Proc Natl Acad Sci 2011; 108:13653-13658.
17. Saetrom P, Biesinger J, Li SM, et al. A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. Cancer Res 2009; 69:7459-7465.
18. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64:31-49.
19. Strausberg RL, Greenhut SF, Grouse LH, Schaefer CF, Buetow KH. In silico analysis of cancer through the Cancer Genome Anatomy Project. Trends Cell Biol 2001; 11:S66-S71.
20. Kruger J, Rehmsmeier M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 2006; 34:451-454.
21. Song F, Zheng H, Liu B, et al. An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset. Clin Cancer Res 2009; 15:6292-6300.
22. Liu Z, Wei S, Ma H, et al. A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. Carcinogenesis 2011; 32:1668-1674.
23. Knol MJ, van der Tweel I, Grobbee DE, Numans ME, Geerlings MI. Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int J Epidemiol 2007; 36:1111-1118.
24. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, a nd genetic association at polymorphism loci. Cell Res 2005; 15:97-98.
25. Zhang H, Jin G, Li H, et al. Genetic variants at 1q22 and 10q23 reproducibly associated with gastric cancer susceptibility in a Chinese population. Carcinogenesis 2011; 32:848-852.
26. Hurteau GJ, Carlson JA, Roos E, Brock GJ. Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression. Cell Cycle 2009; 8:2064-2069.
27. Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10:593-601.
28. Bracken CP, Gregory PA, Kolesnikoff N, et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 2008; 68:7846-7854.
29. Wellner U, Schubert J, Burk UC, et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 2009; 11:1487-1495.
30. Shimono Y, Zabala M, Cho RW, et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009; 138:592-603.
31. Chang CJ, Chao CH, Xia W, et al. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 2011; 13:317-323.
32. Pasquale EB. Eph receptors and ephrins in cancer: Bidirectional signalling and beyond. Nat Rev Cancer 2010; 10:165-180.
33. Wykosky J, Debinski W. The EphA2 receptor and ephrinA1 ligand in solid tumors: Function and therapeutic targeting. Mol Cancer Res 2008; 6:1795-1806.
34. Nakamura R, Kataoka H, Sato N, et al. EPHA2/EFNA1 expression in human gastric cancer. Cancer Sci 2005; 96:42-47.
35. Yuan WJ, Ge J, Chen ZK, et al. Over-expression of EphA2 and EphrinA-1 in human gastric adenocarcinoma and its prognostic value for postoperative patients. Dig Dis Sci 2008; 54:2410-2417.
36. Herath NI, Spanevello MD, Sabesan S, et al. Over-expression of Eph and ephrin genes in advanced ovarian cancer: Ephrin gene expression correlates with shortened survival. BMC Cancer 2006; 6:144.
37. Iida H, Honda M, Kawai HF, et al. Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma. Gut 2005; 54:843-851.
38. Potla L, Boghaert ER, Armellino D, Frost P, Damle NK. Reduced expression of EphrinA1 (EFNA1) inhibits three-dimensional growth of HT29 colon carcinoma cells. Cancer Lett 2002; 175:187-195.
39. Brantley-Sieders DM, Fang WB, Hwang Y, Hicks D, Chen J. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice. Cancer Res 2006; 66:10315-10324.
40. Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433:769-773.
41. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: Determinants beyond seed pairing. Mol Cell 2007; 27:91-105.